yvandenbroek
/
sprookjes
/
Login
Register
TriplyDB
sprookjes
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
GraphQL
BETA
Graphs
2
Q41103172-519C0A54-6101-46B9-98C7-B68697C62D4A
Q41103172-519C0A54-6101-46B9-98C7-B68697C62D4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41103172-519C0A54-6101-46B9-98C7-B68697C62D4A
Agomelatine or ramelteon as treatment adjuncts in glioblastoma and other M1- or M2-expressing cancers.
P2860
Q41103172-519C0A54-6101-46B9-98C7-B68697C62D4A
BestRank
Statement
http://www.wikidata.org/entity/statement/Q41103172-519C0A54-6101-46B9-98C7-B68697C62D4A
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4b380e0b9e885fe414c117c6af316f84359523af
P2860
CUSP9* treatment protocol for recurrent glioblastoma: aprepitant, artesunate, auranofin, captopril, celecoxib, disulfiram, itraconazole, ritonavir, sertraline augmenting continuous low dose temozolomide.